DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) saw a significant growth in short interest in February. As of February 15th, there was short interest totalling 137,800 shares, a growth of 87.5% from the January 31st total of 73,500 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.
DiaSorin Stock Up 9.3 %
Shares of DSRLF opened at $109.60 on Friday. The business’s 50 day moving average is $104.41 and its two-hundred day moving average is $103.37. DiaSorin has a 52-week low of $100.26 and a 52-week high of $109.60.
Wall Street Analyst Weigh In
Separately, UBS Group lowered DiaSorin from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 26th.
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Recommended Stories
- Five stocks we like better than DiaSorin
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- The Most Important Warren Buffett Stock for Investors: His Own
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Stock Splits, Do They Really Impact Investors?
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.